Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Opioid Receptors: Overview01:22

Opioid Receptors: Overview

1.6K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
1.6K
Analgesia and Pain Management01:25

Analgesia and Pain Management

763
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
763
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

342
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
342
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

399
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
399
Vaccinations01:51

Vaccinations

45.2K
Overview
45.2K
Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

835
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
835

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development and Usability of the "FORTEe Get Strong" App to Promote Physical Activity and Health Awareness in Children and Adolescents With Cancer During Intensive Treatment Using an App-Based Approach: Mixed Methods Study.

JMIR serious games·2026
Same author

PROMs: Patient related or patient centred? A bridge between Patient-Reported Outcome Measures (PROMs) and clinical ethics in the context of a cohort of gynaeco-oncological patients analysed by qualitative semi- structured interviews.

Journal of patient-reported outcomes·2026
Same author

How is Racial Discrimination Assessed in Quantitative Health Research? A Systematic Review from a European Perspective.

Journal of racial and ethnic health disparities·2026
Same author

Navigating ethical challenges in the FORTEe randomised controlled trial: a multi-centre staff survey on exercise intervention for children and adolescents undergoing cancer treatment.

BMC medical ethics·2026
Same author

Death wishes and death thoughts in paediatric palliative care: a survey of German healthcare professionals.

BMC palliative care·2025
Same author

Direct RNA sequencing enables improved transcriptome assessment and tracking of RNA modifications for medical applications.

Nucleic acids research·2025

Related Experiment Video

Updated: Aug 28, 2025

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
09:29

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods

Published on: August 4, 2022

2.3K

Lessons from COVID-19 to increase opioid vaccine acceptance.

Roxana Damiescu1, Mita Banerjee2, Norbert W Paul3

  • 1Department of Pharmaceutical Biology, Institute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg University, Staudinger Weg 5, Mainz, Germany.

Trends in Pharmacological Sciences
|September 19, 2022
PubMed
Summary

Vaccine hesitancy, seen with COVID-19 vaccines, may impact the adoption of new opioid vaccines. These vaccines aim to combat opioid addiction, overdoses, and relapse, offering a potential public health breakthrough.

Keywords:
COVID-19 vaccinationopioid misuseopioid vaccinationpublic healthvaccine reluctance

More Related Videos

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
07:44

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

1.3K
Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation
16:02

Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation

Published on: February 10, 2023

2.8K

Related Experiment Videos

Last Updated: Aug 28, 2025

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
09:29

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods

Published on: August 4, 2022

2.3K
Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
07:44

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

1.3K
Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation
16:02

Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation

Published on: February 10, 2023

2.8K

Area of Science:

  • Addiction medicine
  • Vaccinology
  • Public health

Background:

  • Vaccine efficacy and uptake are critical for controlling infectious diseases, as highlighted by the COVID-19 pandemic.
  • Widespread vaccine hesitancy has prolonged the COVID-19 pandemic, underscoring challenges in public health interventions.
  • The opioid crisis remains a significant public health concern, necessitating innovative prevention and treatment strategies.

Purpose of the Study:

  • To explore the potential development and public reception of novel opioid vaccines.
  • To identify parallels between COVID-19 vaccine hesitancy and potential reluctance towards opioid vaccines.
  • To assess the role of opioid vaccines in preventing addiction, overdoses, and relapse, particularly alongside medication-assisted therapy.

Main Methods:

  • Review of current research on opioid vaccine development.
  • Analysis of public health data and trends related to vaccine hesitancy.
  • Comparative study of vaccine acceptance factors for COVID-19 and potential opioid vaccines.

Main Results:

  • Opioid vaccines are under development as a novel strategy to combat the opioid epidemic.
  • Public reluctance towards vaccination, a significant issue during the COVID-19 pandemic, poses a potential challenge for opioid vaccine uptake.
  • Opioid vaccines may serve as a valuable adjunct to medication-assisted therapy for opioid use disorder.

Conclusions:

  • The development of opioid vaccines presents a promising avenue for addressing the ongoing opioid crisis.
  • Anticipating and addressing potential vaccine hesitancy will be crucial for the successful implementation of opioid vaccines.
  • Integrating opioid vaccines with existing treatment modalities could enhance their effectiveness in preventing addiction, overdose, and relapse.